2025
SJR Q2
JCR Q1 · 3,6
OA
8 matched articles
SCIE
Journal detail
European Cells and Materials
- Publisher
- Forum Multimedia Publishing LLC
- Country
- United States · Northern America
- Type
- journal
- ISSN
-
14732262
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,682
- Quartile Q2
- H-Index 101
- Cites/doc 3,27
- Docs (3y) 76
- Cites (3y) 252
Clarivate
Web of Science · JCR · 2025
- JCR Q Q1
- JIF 3,6
- 5Y JIF 3,5
- JCI 0,82
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Biochemistry Q2
- Bioengineering Q2
- Biomaterials Q2
- Biomedical Engineering Q2
- Cell Biology Q3
- Medicine (miscellaneous) Q2
Areas
- Biochemistry, Genetics and Molecular Biology
- Chemical Engineering
- Engineering
- Materials Science
- Medicine
WoS categories
- Cell & Tissue Engineering | Engineering, Biomedical | Materials Science, Biomaterials | Orthopedics
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q1 | 0,682 | 3,6 | 3,5 | 0,82 | Q2 | 101 |
| 2024 | Q2 | Q1 | 0,76 | 3,1 | 3,3 | 0,84 | Q2 | 99 |
| 2023 | Q2 | Q1 | 0,7 | 3,2 | 3,4 | 0,83 | Q2 | 99 |
| 2022 | Q2 | Q1 | 0,728 | 3,1 | 4,1 | 0,91 | Q2 | 99 |
| 2021 | Q2 | Q1 | 0,709 | 4,3 | 5,1 | 1 | Q2 | 99 |
| 2020 | Q1 | Q1 | 1,066 | 3,9 | 4,8 | 1,05 | Q1 | 99 |
| 2019 | Q1 | Q1 | 1,141 | 3,7 | 4,3 | 1,1 | Q1 | 99 |
| 2018 | — | Q1 | — | 3,7 | 4,4 | 1,11 | Q1 | — |
| 2017 | Q1 | Q1 | 1,345 | 3,7 | 4,8 | 1,11 | Q1 | 99 |
| 2016 | Q1 | Q1 | 1,403 | 4 | 5,2 | — | — | 99 |
| 2015 | Q1 | Q1 | 1,795 | 4,6 | 5,7 | — | — | 99 |
| 2014 | Q2 | Q1 | 0,66 | 4,9 | 6 | — | — | 99 |
| 2013 | Q2 | Q1 | 0,391 | 4,9 | 6 | — | — | 99 |
| 2012 | Q3 | Q1 | 0,294 | 4,6 | 5,7 | — | — | 99 |
| 2011 | Q3 | Q2 | 0,234 | 3 | 5 | — | — | 99 |
| 2010 | Q3 | Q1 | 0,192 | 9,7 | — | — | — | 99 |
| 2009 | — | Q1 | — | 5,4 | — | — | — | — |
| 2008 | — | Q1 | — | 4,3 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | CELL & TISSUE ENGINEERING | SCIE | Q3 | Q2 | 18/32 |
| 2025 | ENGINEERING, BIOMEDICAL | SCIE | Q2 | Q2 | 59/130 |
| 2025 | MATERIALS SCIENCE, BIOMATERIALS | SCIE | Q3 | Q2 | 34/58 |
| 2025 | ORTHOPEDICS | SCIE | Q1 | Q2 | 24/147 |
| 2024 | CELL & TISSUE ENGINEERING | SCIE | Q3 | Q2 | 20/32 |
| 2024 | ENGINEERING, BIOMEDICAL | SCIE | Q2 | Q2 | 61/124 |
| 2024 | MATERIALS SCIENCE, BIOMATERIALS | SCIE | Q3 | Q2 | 37/55 |
| 2024 | ORTHOPEDICS | SCIE | Q1 | Q2 | 25/140 |
| 2023 | CELL & TISSUE ENGINEERING | SCIE | Q3 | Q2 | 19/31 |
| 2023 | ENGINEERING, BIOMEDICAL | SCIE | Q2 | Q2 | 56/123 |
| 2023 | MATERIALS SCIENCE, BIOMATERIALS | SCIE | Q3 | Q2 | 33/53 |
| 2023 | ORTHOPEDICS | SCIE | Q1 | Q2 | 18/136 |
| 2022 | CELL & TISSUE ENGINEERING | SCIE | Q3 | Q2 | 21/29 |
| 2022 | ENGINEERING, BIOMEDICAL | SCIE | Q3 | Q2 | 58/96 |
| 2022 | MATERIALS SCIENCE, BIOMATERIALS | SCIE | Q4 | Q2 | 34/45 |
| 2022 | ORTHOPEDICS | SCIE | Q1 | Q2 | 21/86 |
| 2021 | CELL & TISSUE ENGINEERING | SCIE | Q3 | Q2 | 17/29 |
| 2021 | ENGINEERING, BIOMEDICAL | SCIE | Q2 | Q2 | 41/98 |
| 2021 | MATERIALS SCIENCE, BIOMATERIALS | SCIE | Q3 | Q2 | 23/45 |
| 2021 | ORTHOPEDICS | SCIE | Q1 | Q2 | 14/86 |
| 2020 | CELL & TISSUE ENGINEERING | SCIE | Q3 | Q2 | 18/29 |
| 2020 | ENGINEERING, BIOMEDICAL | SCIE | Q2 | Q1 | 30/89 |
| 2020 | MATERIALS SCIENCE, BIOMATERIALS | SCIE | Q3 | Q2 | 21/41 |
| 2020 | ORTHOPEDICS | SCIE | Q1 | Q1 | 16/82 |
| 2019 | CELL & TISSUE ENGINEERING | SCIE | Q3 | Q2 | 15/29 |
| 2019 | ENGINEERING, BIOMEDICAL | SCIE | Q1 | Q1 | 21/87 |
| 2019 | MATERIALS SCIENCE, BIOMATERIALS | SCIE | Q2 | Q1 | 16/38 |
| 2019 | ORTHOPEDICS | SCIE | Q1 | Q1 | 11/82 |
| 2018 | CELL & TISSUE ENGINEERING | SCIE | Q2 | Q2 | 11/26 |
| 2018 | ENGINEERING, BIOMEDICAL | SCIE | Q1 | Q1 | 15/80 |
| 2018 | MATERIALS SCIENCE, BIOMATERIALS | SCIE | Q2 | Q1 | 12/32 |
| 2018 | ORTHOPEDICS | SCIE | Q1 | Q1 | 8/76 |
| 2017 | CELL & TISSUE ENGINEERING | SCIE | Q2 | Q1 | 11/24 |
| 2017 | ENGINEERING, BIOMEDICAL | SCIE | Q1 | Q1 | 14/78 |
| 2017 | MATERIALS SCIENCE, BIOMATERIALS | SCIE | Q2 | Q1 | 12/33 |
| 2016 | CELL & TISSUE ENGINEERING | SCIE | Q1 | — | 5/21 |
| 2016 | ENGINEERING, BIOMEDICAL | SCIE | Q1 | — | 8/77 |
| 2016 | MATERIALS SCIENCE, BIOMATERIALS | SCIE | Q2 | — | 11/33 |
| 2015 | CELL & TISSUE ENGINEERING | SCIE | Q1 | — | 5/21 |
| 2015 | ENGINEERING, BIOMEDICAL | SCIE | Q1 | — | 8/76 |
| 2015 | MATERIALS SCIENCE, BIOMATERIALS | SCIE | Q1 | — | 6/33 |
| 2014 | CELL & TISSUE ENGINEERING | SCIE | Q2 | — | 6/21 |
| 2014 | ENGINEERING, BIOMEDICAL | SCIE | Q1 | — | 6/76 |
| 2014 | MATERIALS SCIENCE, BIOMATERIALS | SCIE | Q1 | — | 5/33 |
| 2013 | CELL & TISSUE ENGINEERING | SCIE | Q1 | — | 3/18 |
| 2013 | ENGINEERING, BIOMEDICAL | SCIE | Q1 | — | 4/76 |
| 2013 | MATERIALS SCIENCE, BIOMATERIALS | SCIE | Q1 | — | 4/32 |
| 2012 | CELL & TISSUE ENGINEERING | SCIE | Q1 | — | 4/17 |
| 2012 | ENGINEERING, BIOMEDICAL | SCIE | Q1 | — | 4/79 |
| 2012 | MATERIALS SCIENCE, BIOMATERIALS | SCIE | Q1 | — | 3/27 |
| 2011 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | — | 126/290 |
| 2011 | MATERIALS SCIENCE, BIOMATERIALS | SCIE | Q2 | — | 7/25 |
| 2010 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q1 | — | 20/286 |
| 2010 | MATERIALS SCIENCE, BIOMATERIALS | SCIE | Q1 | — | 1/25 |
| 2009 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q1 | — | 46/283 |
| 2009 | MATERIALS SCIENCE, BIOMATERIALS | SCIE | Q1 | — | 2/25 |
| 2008 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | — | 69/275 |
| 2008 | MATERIALS SCIENCE, BIOMATERIALS | SCIE | Q1 | — | 2/20 |